Literature DB >> 16987813

Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster.

Sung-Soo Park1, Jung-Mo Kim, Dae-Seok Kim, In-Hoo Kim, Soo-Youl Kim.   

Abstract

Recently we reported that transglutaminase 2 (TGase 2) activates nuclear factor-kappaB (NF-kappaB) independently of I-kappaB kinase (IKK) activation, by inducing cross-linking and protein polymer formation of inhibitor of nuclear factor-kappaBalpha (I-kappaBalpha). TGase 2 catalyzes covalent isopeptide bond formation between the peptide bound-glutamine and the lysine residues. Using matrix-assisted laser desorption ionization time-of-flight mass spectra analysis of I-kappaBalpha polymers cross-linked by TGase 2, as well as synthetic peptides in an in vitro competition assay, we identified a glutamine cluster at the C terminus of I-kappaBalpha (amino acids 266-268) that appeared to play a key role in the formation of I-kappaBalpha polymers. Although there appeared to be no requirement for specific lysine residues, we found a considerably higher preference for the use of lysine residues at positions 21, 22, and 177 in TGase 2-mediated cross-linking of I-kappaBalpha. We demonstrated that synthetic peptides encompassing the glutamine cluster at amino acid positions 266-268 reversed I-kappaBalpha polymerization in vitro. Furthermore, the depletion of free I-kappaBalpha in EcR/TG cells was completely rescued in vivo by transfection of mutant I-kappaBalphas in glutamine sites (Q266G, Q267G, and Q313G) as well as in a lysine site (K177G). These findings provide additional clues into the mechanism by which TGase 2 contributes to the inflammatory process via activation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987813     DOI: 10.1074/jbc.M604150200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.

Authors:  Bo Mi Ku; Se-Jin Kim; Nayeon Kim; Dongwan Hong; Yong-Bock Choi; Seon-Hyeong Lee; Young-Dae Gong; Soo-Youl Kim
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-08       Impact factor: 4.553

2.  Transglutaminase-catalyzed incorporation of polyamines masks the DNA-binding region of the transcription factor Relish.

Authors:  Kouki Maki; Toshio Shibata; Shun-Ichiro Kawabata
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

3.  Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.

Authors:  Kang-Seo Park; Hyun-Kyoung Kim; Jung-Hwa Lee; Yong-Bock Choi; Seong-Yeol Park; Sei-Hoon Yang; Soo-Youl Kim; Kyeong-Man Hong
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-18       Impact factor: 4.553

4.  Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.

Authors:  Seon-Hyeong Lee; Nayeon Kim; Se-Jin Kim; Jaewhan Song; Young-Dae Gong; Soo-Youl Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-21       Impact factor: 4.553

5.  Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.

Authors:  Nasim Shweke; Nada Boulos; Chantal Jouanneau; Sophie Vandermeersch; Gerry Melino; Jean-Claude Dussaule; Christos Chatziantoniou; Pierre Ronco; Jean-Jacques Boffa
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

6.  The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.

Authors:  Kyung-Chae Jeong; Kyung-Ohk Ahn; Byung Il Lee; Chang-Hoon Lee; Soo-Youl Kim
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

7.  Bcr is a substrate for Transglutaminase 2 cross-linking activity.

Authors:  Sun-Ju Yi; John Groffen; Nora Heisterkamp
Journal:  BMC Biochem       Date:  2011-02-10       Impact factor: 4.059

8.  Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.

Authors:  Keunhee Oh; Hyung-Bae Park; Ok-Jin Byoun; Dong-Myung Shin; Eui Man Jeong; Young Whan Kim; Yon Su Kim; Gerry Melino; In-Gyu Kim; Dong-Sup Lee
Journal:  J Exp Med       Date:  2011-07-11       Impact factor: 14.307

Review 9.  Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death.

Authors:  H Tatsukawa; Y Furutani; K Hitomi; S Kojima
Journal:  Cell Death Dis       Date:  2016-06-02       Impact factor: 8.469

10.  Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition.

Authors:  Seon-Hyeong Lee; Won-Kyu Lee; Nayeon Kim; Joon Hee Kang; Kyung-Hee Kim; Seul-Gi Kim; Jae-Seon Lee; Soohyun Lee; Jongkook Lee; Jungnam Joo; Woo Sun Kwon; Sun Young Rha; Soo-Youl Kim
Journal:  Cancers (Basel)       Date:  2018-11-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.